Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail
-

Patent and Exclusivity Search Results from query on Appl No 021676 Product 001 in the OB_Rx list.


Patent Data

Appl No Prod No Patent No Patent
Expiration
Drug Substance
Claim
Drug Product
Claim
Patent Use
Code
Delist
Requested
N021676 001 5569652 Oct 29, 2013 U - 1
N021676 001 5798338 Jul 10, 2015 Y
N021676 001 6787531 Aug 31, 2020 Y
N021676 001 6933395 Aug 11, 2017 Y
N021676 001 6958326 Dec 20, 2021 Y
N021676 001 6987101 Dec 22, 2017 U - 758
N021676 001 7163931 Dec 20, 2021 U - 1
N021676 001 RE37564 Jun 30, 2014 Y
N021676 001 RE37838 Jun 30, 2014 Y
N021676 001 RE38253 Jun 30, 2014 Y
N021676 001 RE43916 Jun 30, 2014 U - 1326

Exclusivity Data

There is no unexpired exclusivity for this product.


Additional information:

  1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
  2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be flagged with respect to other claims which may apply.


View a list of all patent use codes
View a list of all exclusivity codes

Return to Electronic Orange Book Home Page


FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through March 01, 2014
Patent and Generic Drug Product Data Last Updated April 17, 2014

-
-